Paulash Mohsen
Chief Executive Officer at Vesigen, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Richard Peters | M | 61 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | 3 years |
Douglas Lankler | M | 58 | 25 years | |
Marie N. Epstein | F | - |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | 6 years |
Sally Susman | F | 62 | 17 years | |
Dieter Weinand | M | 63 |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 7 years |
Suzanne Johnson | F | 66 | 17 years | |
Markus Green | M | - | 18 years | |
Mike McDermott | M | 58 | 21 years | |
Payal Sahni Becher | F | - | 27 years | |
Stephen Bruso | M | - |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 4 years |
Lucio Iannone | M | 41 |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 4 years |
Denis Patrick | M | - | 14 years | |
Jürgen Eckhardt | M | 57 |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 4 years |
Suneet Varma | M | 55 | 23 years | |
Brigitte Robertson | M | - |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
Jak Knowles | M | - |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 4 years |
David Arkowitz | M | 62 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
Mikael Dolsten | M | 65 | 15 years | |
Lok Chung Chan | M | 73 |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 4 years |
Jeffery Kelly | M | 63 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
Richard Heyman | M | 66 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
N. Coles | M | 63 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
Cecil B. Pickett | M | 78 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
Barbara Dalton | M | 69 | 17 years | |
Lynne Zydowsky | M | 65 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
Annaliesa Anderson | M | - | 17 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert A. Millman | M | - |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | - |
Henry McKinnell | M | 81 | 8 years | |
Jeffrey Kindler | M | 68 | 8 years | |
Dennis Ausiello | M | 78 | 13 years | |
George A. Lorch | M | 82 | 15 years | |
Amy Schulman | F | 63 | 6 years | |
David Shedlarz | M | 75 | 31 years | |
John Mascotte | M | 84 | 4 years | |
Patricia Allen | F | 62 | - | |
Mace Rothenberg | M | 67 | 13 years | |
Olivier Brandicourt | M | 68 | 13 years | |
Martin MacKay | M | 68 | 14 years | |
Alan Levin | M | 62 | 20 years | |
Robert Landry | M | 60 | 4 years | |
Paul Fitzhenry | M | 64 | 4 years | |
Jacob M. Plotsker | M | 56 | 16 years | |
Everett Cunningham | M | 57 | 9 years | |
Devin Smith | M | 56 | - | |
Ranjeev Krishana | M | 50 | 7 years | |
Jonathan Emms | M | - | 20 years | |
Yi Ning Zhao | M | 53 | 8 years | |
Jennifer Schroeder | F | - | 20 years | |
Alexandra Kropotova | M | 51 | 5 years | |
Frank D'Amelio | M | 66 | 14 years | |
Michael Wyzga | M | 35 | - | |
Michael R. Jirousek | M | 65 | 5 years | |
Wyllie Cornwell | M | 76 | 23 years | |
Freda Lewis-Hall | M | 69 | 11 years | |
George Milne | M | 80 | 32 years | |
Dana George Mead | M | 88 | 12 years | |
Stephen W. Sanger | M | 78 | 9 years | |
Peter Corr | M | 76 | 6 years | |
Frances Fergusson | M | 79 | 9 years | |
William Herbert Gray | M | 82 | 13 years | |
Robert N. Burt | M | 86 | 11 years | |
James Kilts | M | 76 | 13 years | |
Michael Bruce | M | - | 12 years | |
Cara Cassino | M | 62 | 5 years | |
Robert Zerbe | M | 73 | 7 years | |
Yacoub Habib | M | 56 | 2 years | |
Lisa Ricciardi | F | 64 | - | |
John Porter | M | 53 | 5 years | |
Dawn Rogers | F | 59 | - | |
Karin Jooss | M | 59 | 7 years | |
Robyn Peters | F | - | 4 years | |
Angela Hwang | F | 58 | 26 years | |
Robert E. Grasty | M | 55 | - | |
Ian Taylor | M | 61 | 9 years | |
Glenn Miles | M | 58 | 4 years | |
John W. Poyhonen | M | 64 | 7 years | |
Brian Krex | M | 57 | 9 years | |
Victor Micati | M | 83 | 34 years | |
David Roth | M | 61 | 4 years | |
Scott Cheshareck | M | - | 16 years | |
Walter S. Hauck | M | 64 | 13 years | |
Eliot Forster | M | 58 | 11 years | |
John Henderson | M | 79 | - | |
Feargal Mooney | M | 54 | 3 years | |
John F. Niblack | M | 85 | 35 years | |
Wesley W. Day | M | 59 | 12 years | |
James New | M | 70 | 5 years | |
Frank Sciavolino | M | 83 | 35 years | |
Julie A. Olson | M | - | 19 years | |
James Bristol | M | 77 | 4 years | |
Kim Seth | M | - | 3 years | |
Loretta Ucelli | F | - | - | |
George W. Evans | M | 70 | 26 years | |
Tanya Clemons | M | - | - | |
Tatyana Daniels | F | - | - | |
Thomas G. Gant | M | - | 6 years | |
James H. Heym | M | - | 24 years | |
John Thompson | M | 57 | 7 years | |
Anna Berkenblit | M | 54 | 4 years | |
Catherine Mackey | M | 68 | 11 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paulash Mohsen
- Personal Network